All News

A study from the University of Michigan found that only 1 in 6 emergency department visits for an opioid overdose in the United States result in a prescription for buprenorphine, methadone, or extended-release naltrexone.

Pharmacists at nearly 2 dozen CVS pharmacy locations called out sick Thursday and Friday to protest recent corporate decisions they say put patients at risk of serious harm.

Your weekly roundup of the latest news from Drug Topics®.

Treatment with buprenorphine has more than doubled since 2009, but dosing guidelines are based on studies with people using heroin that were done before the fentanyl crisis.

The Ohio Board of Pharmacy found during several inspections that some CVS stores in the state had dirty conditions, a lack of control over dangerous medications, and months-long wait times for medications.

Your weekly roundup of the latest news from Drug Topics®.

A 1-year observational follow-up of a 3-month randomized controlled trial provides insight into the benefits of advanced hybrid closed-loop system use in people with type 1 diabetes using multiple daily injections and self-monitoring of blood glucose.

Michael Ganio, PharmD, MS, senior director of pharmacy practice and quality at the American Society of Health-System Pharmacists (ASHP), sat down with Drug Topics to discuss the current drug shortages and how pharmacists are dealing with them.

FDA sends warning letters to 8 companies over unapproved eye drops, healthcare visits delivered by nurse practitioners and physician assistants continue to increase, and WHO agrees on the first-ever patient safety rights charter.

The CDC weighs in on updated COVID-19 vaccines, the FDA says phenylephrine is ineffective, and heath care workers in California get a pay raise.

Drugs like Ozempic and Wegovy, two semaglutide products made by Novo Nordisk, as well as Mounjaro (tirzepatide), mimic a hormone called glucagon-like peptide-1 (GLP-1) that targets areas of the brain that regulate appetite and food intake.

CDC to weigh who should get updated COVID-19 vaccines after FDA approval, Novavax says its updated COVID-19 vaccine is ready for distribution, and Walgreens partners with Pearl Health to expand primary care services.

The Vice President of Industry Relations at IQVIA gave a presentation at the 2023 PBMI Annual National Conference in Orlando, where he discussed everything from healthcare utilization during COVID-19 to spending on specialty drugs.

Your weekly roundup of the latest news from Drug Topics®.

CDC survey finds Interventions are needed to facilitate the implementation of updated pneumococcal vaccine recommendations, HHS proposes a new rule the seeks to prohibit discrimination based on disabilities, and a new report says there is a need for improved access to pediatric subspecialty care.

Updated COVID-19 booster shots may be approved by Friday, health insurance costs continue to increase, and republicans with 3 house committees plan to introduce PBM reform bill.

The CDC issues an alert for increased RSV activity, a survey finds men's habits don't stack up to their perceptions on their health, and the WHO announces an air pollution training course for health care workers.

The 2023 Healthcare Advocate Summit is September 5 to 9 in New Orleans, Louisiana.

Your weekly roundup of the latest news from Drug Topics®.

The FDA plans to finalize its ban on menthol tobacco products in the coming months, and the Department of Health and Human Services proposes comprehensive staffing requirements for nursing homes.

Your monthly roundup of the top news from Drug Topics®.

The FDA issues warning letters to 3 infant formula manufacturers for violations, and officials with the Department of Health and Human Services recommend reclassifying marijuana as a schedule III drug.

Sometimes, breaches in information are the result of a simple mistake. How can those be avoided?

Narcan is set to be available at several drugstore and grocery chains in the US early next week, and Walmart announced a new "Testing and Treatment" program at its pharmacies in 12 states.

CMS announces the first 10 drugs selected for price negotiation under Medicare Part D, and a new study finds prescriptions for fruits and vegetables can improve health outcomes for people at increased risk of cardiovascular disease.

Your weekly roundup of the latest news from Drug Topics®.